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Many commonly used pharmaceutical agents have been found to inhibit
bacterial growth in vitro. Determinations of antimicrobial concentrations in sera
of patients taking nonrecognized antibacterial agents could possibly be altered if
bioassay systems are utilized for the determinations. We therefore attempted to
determine the in vitro effect of commonly used drugs on bioassay indicator
organisms. Fifty-one different agents (antihistamines, anticholinergics, central
nervous, system agents, cardiovascular agents, analgesics, steroids, muscle
blockers, and other miscellaneous agents) were tested for inhibition or enhance-
ment of the growth of Bacillus subtilis, Staphylococcus aureus, Micrococcus
luteus, and Klebsiella pneumoniae. None of the agents tested exhibited any effect
on standard in vitro bioassay organisms. Nortriptyline hydrochloride inhibited the
growth of B. subtilis and M. luteus at a concentration of 500 ,ug/ml (zones of
inhibition, 14 and 13 mm, respectively), but no inhibition was observed with
concentrations of 50 ,g/ml or lower.
Pharmaceutical agents not usually classified
as antibacterial agents have been found to inhibit
bacterial growth in vitro. Non-antibacterial
agents such as promazine (4), caffeine (3), theo-
phyiline (3), heparin (10), and ascorbic acid (9)
are reported to possess bacteriostatic or bacteri-
cidal properties, often at their usual serum con-
centrations. Other classes of agents (e.g., cancer
chemotherapy drugs [11], anesthetics [8, 12], or
steroid hormones [6]) or derivatives of certain
classes (e.g., barbituric acids [1, 2] and benzo-
diazepines [7]) have demonstrated similar prop-
erties.
Since a wide variety of drugs demonstrate in
vitro antibacterial activity, other agents in com-
mon clinical usage may also possess such activi-
ty. Therefore, patients taking nonrecognized
antibacterial agents may have serum concentra-
tions sufficient to influence bacterial growth in
vitro. A specific concern is that determinations
of antimicrobial concentrations in the sera of
patients taking nonrecognized antibacterial
agents may be altered if bioassay systems are
utilized for the determinations.
Our interest originated when intraoperative
concentrations of cephalosporins were deter-
mined in the sera of patients undergoing surgical
procedures. Many such patients receive 10 or
more medications in the perioperative period,
and it was considered essential to determine the
effect of these frequently administered agents on
in vitro bioassay systems. To our knowledge, no
comprehensive information is available in the
literature describing the effect of commonly
used non-antibacterial agents on in vitro bioas-
say systems.
MATERIALS AND METHODS
Agents tested. A list of the agents tested is given in
Table 1. Each of the agents was obtained from the
pharmaceutical manufacturers as pure powder with no
preservatives or other additives. For each agent a
solution was prepared with a final concentration of
4.16 mg/ml. The agents were dissolved in distilled
water or, if necessary, 95% ethanol or dilute sodium
hydroxide. From each of these solutions, 0.3 ml was
removed and mixed individually with 2.2 ml of serum
from normal volunteers, resulting in a final drug con-
centration of 500 ,g/ml. The solutions were mixed by
vortexing and then frozen (-20°C) until analysis. For
this screening of assay interference, concentrations
much greater than those usually achieved in vivo were
desired. Each of the solutions was then tested in the
manner described below.
Bioassay. Bacillus subtilis ATCC 6633 spore suspen-
sions were obtained from Difco Laboratories; Staphy-
lococcus aureus ATCC 6538P, Micrococcus luteus
ATCC 9341, and a multiply resistant strain of Klebsiel-
la pneumoniae (ATCC 27799) were lyophilized prepa-
rations from the American Type Culture Collection.
Assay plates were prepared the day of use with Difco
antibiotic medium no. 1 (S. aureus), no. 5 (B. subtilis),
or no. 11 (M. luteus and K. pneumoniae) as described
previously (5). Plastic petri dishes (100 by 15 mm;
Falcon Plastics) were used with agar volumes of 5 or
10 ml (B. subtilis) or 9 ml (S. aureus, M. luteus, and K.
pneumoniae). Aliquots (20 RI) of the drug solutions
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TABLE 1. Agents used in this study
Type of agent
Antihistamine-anticholin-
ergic
Central nervous system
Miscellaneous
Name i Type of agent Name
Atropine Probenecid
Chlorpheniramine male-
ate
Cimetidine hydrochlo-
ride
Diphenhydramine hydro-
chloride
Glycopyrrolate
Hydroxyzine hydrochlo-
ride
Amitriptyline hydrochlo-
ride
Chlorpromazine hydro-
chloride
Diazepam
Flurazepam
Imipramine hydrochlo-
ride
Nortriptyline hydrochlo-
ride
Phenobarbital
Phenytoin sodium
Promethazine hydro-
chloride
Secobarbital
Allopurinol
Ascorbic acid
Caffeine
Colchicine
Ephedrine hydrochloride
Heparin sodium (beef)
Heparin sodium (por-
cine)
Cardiovascular
Analgesic
Muscle blocker
Steroid
Theophylline
Warfarin sodium
Clonidine hydrochloride
Chlorothiazide
Chlorthalidone
Digoxin
Hydrochlorothiazide
Hydralazine hydrochlo-
ride
Lidocaine hydrochloride
N-Acetyl procainamide
hydrochloride
Propranolol hydrochlo-
ride
Quinidine sulfate
Spironolactone
Acetaminophen
Aspirin
Ibuprofen
Meperidine hydrochlo-
ride
Morphine sulfate
Propoxyphene hydro-
chloride
Pancuronium bromide
Succinyl choline
Tubocurarine hydrochlo-
ride
Hydrocortisone
Prednisolone
Prednisone
Progesterone
were pipetted onto sterile 6-mm filter paper disks
(Difco) and applied to the agar surface; control disks
containing the solvents and antibiotic disks (BBL
Microbiology Systems) containing 10 ,ug of penicillin,
10 Fg of ampicillin, 30 ,ug of cefoxitin, 30 ,ug of
chloramphenicol, and 10 p.g ofgentamicin were includ-
ed in each assay. The unstacked plates were incubated
overnight at 35C, and zone sizes were recorded to the
nearest millimeter.
RESULTS
The majority of agents demonstrated no inhi-
bition or enhancement of bacterial growth. Ini-
tial testing of hydrochlorothiazide and chlorothi-
azide resulted in zones of inhibition (for B.
subtilis only) of 11 and 10 mm, respectively.
However, similar zone sizes were seen with
their sodium hydroxide solvent, and on repeat
testing no inhibition was detected when concen-
trations of sodium hydroxide diluent were re-
duced. The initial sample of nortriptyline hydro-
chloride (diluted in distilled water) produced
zones of inhibition of 10 and 12 mm forM. luteus
and B. subtilis, respectively. Subsequent testing
of two additional lots of nortriptyline hydrochlo-
ride demonstrated similar inhibition. The water
diluent failed to inhibit any of the microorga-
nisms. When agar thickness was increased (a
total of 10 ml of agar), the zone of inhibition for
B. subtilis was 8 mm. Nortriptyline dilutions of
50, 5, 0.5, and 0.05 ,ug/ml demonstrated no
inhibition of B. subtilis or M. luteus. When
commercially obtained antibiotic disks were
tested with the same systems, the expected large
zones of bacterial growth inhibition were ob-
served.
DISCUSSION
Pharmaceutical agents in common clinical
use, although studied at greater concentrations
than usually achievable in vivo, exhibited no
independent effect on standard in vitro proce-
dures used to determine in vivo antimicrobial
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concentrations. However, nortriptyline hydro-
chloride demonstrated significant inhibition of
B. subtilis and M. luteus at 500 ,ug/ml, but not at
concentrations usually found in vivo. Since the
test agents were not examined in the presence of
antimicrobial agents the effect on actual antimi-
crobial assays cannot be stated, but it is likely
that there would be minimal interference.
Despite the large number of reports of the
antimicrobial activity of nonrecognized antibac-
terial agents the agents that we examined failed
to show significant influence on bioassay indica-
tor organisms.
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